secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renovacor, Inc. (—)
CIK:        0001799850
Form:       8-K
Filed at:   2022-12-01T23:59:59+00:00
Accession:  0001193125-22-296600
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renovacor acquired by Rocket Pharmaceuticals; shareholders to receive 0.1763 Rocket shares per share
--------------------------------------------------------------------------------

- Acquisition closed Dec 1, 2022; each Renovacor share converted into 0.1763 Rocket shares.
- Renovacor delisted from NYSE American; reporting obligations to be terminated via Form 15.
- All directors (Gbola Amusa, Edward Benz, etc.) and officers resigned effective at closing.
- Stockholders voted overwhelmingly to adopt the merger: 14,716,307 for, 1,000 against.
- Company becomes wholly owned subsidiary of Rocket Pharmaceuticals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/0001193125-22-296600-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799850/000119312522296600/d256474d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-296600

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer